Crossref
Should Bone-Targeted Agents be Standard of Care in Postmenopausal Patients with Early Breast Cancer?
Breast Cancer Management · 2017
DOI: 10.2217/bmt-2016-0025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Breast Cancer Management, 2017. Verfasst von Catherine M Kelly und 2 weiteren Autor:innen. Die Arbeit nennt 25 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Kelly, C. M., Komanyane, L., & Andreopoulou, E. (2017). Should Bone-Targeted Agents be Standard of Care in Postmenopausal Patients with Early Breast Cancer?. Breast Cancer Management. https://doi.org/10.2217/bmt-2016-0025
Vancouver
Kelly CM, Komanyane L, Andreopoulou E. Should Bone-Targeted Agents be Standard of Care in Postmenopausal Patients with Early Breast Cancer?. Breast Cancer Management. 2017. doi:10.2217/bmt-2016-0025
BibTeX
@article{Kelly2017,
author = {Kelly, Catherine M and Komanyane, Lore and Andreopoulou, Eleni},
title = {Should Bone-Targeted Agents be Standard of Care in Postmenopausal Patients with Early Breast Cancer?},
journal = {Breast Cancer Management},
year = {2017},
doi = {10.2217/bmt-2016-0025}
}
EUVIMED